Last reviewed · How we verify
NCT05086991: AIHEMAF - P
AIHEMAF - P "An Innovative Healthcare Model for AF Patients"
trial testing Follow up in Atrial Fibrillation in 50 participants. Completed in 1 April 2023.
1 April 2023
Quick facts
| Lead sponsor | Farmacia La Regina s.r.l. |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 50 |
| Start date | 1 October 2021 |
| Primary completion | 1 April 2023 |
| Estimated completion | 1 April 2023 |
| Sites | 1 location across Italy |
Drugs / interventions tested
- Follow up
Conditions studied
- Atrial Fibrillation — all drugs for Atrial Fibrillation →
Sponsor
Farmacia La Regina s.r.l.
Who can join
Eligibility, any sex, with Atrial Fibrillation. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Non-profit observational study on the role of the community pharmacist and "the pharmacy of services" in the case management of patients suffering from atrial fibrillation and being treated with new generation oral anticoagulants
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
AIHEMAF-P: An Innovative Healthcare Model for Atrial Fibrillation Patients.
La Regina R, Innelli P, Glisenti F, Bollani G, et al · · 2024 · PMID 39728852 · DOI 10.3390/pharmacy12060187
Verify or expand the search:
- PubMed search for NCT05086991
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Follow up
Trials testing the same drug.
- NCT06779344 — MxA and CRP-Guided Use of Antimicrobial Agents for AECOPD · NA · not yet recruiting
- NCT06137352 — Two Domestic HPV Vaccines and Imported HPV Vaccines in Women Aged 13-14 Years Study on Immunogenicity · not yet recruiting
- NCT05745597 — Prognostic Study of HPV Virus Integration in Women With HSIL · unknown
- NCT05282095 — Effect of HPV Integration on Prognosis of Young Women With CIN2 in China · recruiting
- NCT05123417 — Knowledge and Practices of Preventing Pressure Ulcers · NA · completed
Other recruiting trials for Atrial Fibrillation
Currently open trials in the same condition.
- NCT07429214 — A Study of VARIPULSE Catheter and TRUPULSE Generator With VARIPULSE Pro Software in Participants With PAF or PsAF · NA · recruiting
- NCT07271238 — Feasibility Study on the VERAFEYE Imaging and Navigation System for Guided Catheter Ablation Procedures · NA · recruiting
- NCT07388108 — Atrial Dyssynchrony to Predict Arrhythmias in the Postoperative Setting of Cardiovascular Surgery. · recruiting
- NCT07428967 — AV Node Ablation and CONDUCTion System Pacing for Atrial Fibrillation With Preserved Left Ventricular Function · NA · recruiting
- NCT06650995 — AlEX-DHF: Ablation and Exercise in Diastolic Heart Failure · NA · recruiting
Other Farmacia La Regina s.r.l. trials
Trials by the same sponsor.
- NCT03752567 — New Patient Support Program in Type 2 Diabetes · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05086991 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Farmacia La Regina s.r.l.
- Last refreshed: 10 October 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05086991.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing